Merrimack Pharmaceuticals
MACK
#8017
Rank
NZ$0.39 B
Marketcap
$26.47
Share price
0.00%
Change (1 day)
7.06%
Change (1 year)

EPS for Merrimack Pharmaceuticals (MACK)

EPS in 2023 (TTM): -$0.18

According to Merrimack Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.19. In 2022 the company made an earnings per share (EPS) of -$0.19 an increase over its 2021 EPS that were of -$0.31.

EPS history for Merrimack Pharmaceuticals from 2010 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.18-6.02%
2022-$0.19-38.89%
2021-$0.31-25%
2020-$0.42-81.54%
2019-$2.27-56.95%
2018-$5.28-108.5%
2017$62.12-390.35%
2016-$21.39-7.35%
2015-$23.0965%
2014-$13.99-39.39%
2013-$23.09-54.01%
2012-$50.20-53.71%
2011-$108.4640.37%
2010-$77.27

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$5.56-2,991.14%๐Ÿ‡ซ๐Ÿ‡ท France
-$1.47 663.64%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.59 209.09%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.31 1,618.18%๐Ÿ‡บ๐Ÿ‡ธ USA
-$9.87 5,027.27%๐Ÿ‡บ๐Ÿ‡ธ USA